View More View Less
  • 1 University of Szeged Institute of Clinical Microbiology Szeged Hungary
  • | 2 University of Szeged Institute of Anaesthesiology and Intensive Care Szeged Hungary
  • | 3 University of Szeged Department of Infectious Diseases, First Clinic of Internal Medicine Szeged Hungary
  • | 4 University of Szeged Department of Infectious Disease, First Department of Internal Medicine Kálvária sgt. 57 H-6725 Szeged Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The incidence of Candida species causing bloodstream infections in the University Hospital of Szeged, Hungary, between 1996 and 2009, and the susceptibilities of these isolates to antifungal agents were evaluated.Automated blood culture systems (Vital, bioMérieux, Marcy-l’Etoile, France; and BACTEC 9120, Becton-Dickinson Diagnostic Systems, Sparks, USA) were used. The in vitro susceptibilities of the yeast isolates to antifungal agents were determined by the Etest method (AB Biodisk, Solna, Sweden).Bloodstream infections were caused by yeast strains in 231 cases during this period, and 226 Candida strains were cultured from 216 candidaemia patients. Bloodstream infections caused by multiple Candida spp. were diagnosed almost every year. Of the 216 patients, 67 were children; and 55 infants needed intensive care. In 2005, C. glabrata caused an increase in the incidence of invasive fungal infections in the Neonatal Intensive Care Unit. The PFGE analysis of 12 isolates distinguished 4 different karyotypes. The incidence of bloodstream infections caused by fungi did not change during the 14-year study period. The most frequent species cultured from blood samples were C. albicans and C. glabrata. The incidence of resistant isolates remained constant. The local trends of fungaemia must be monitored and compared with global reports.

  • Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., Tvede, M.: Seminational surveillance of fungemia in Denmark: Notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J. Clin. Microbiol. 43, 4434–4440 (2005).

    Tvede M. , 'Seminational surveillance of fungemia in Denmark: Notably high rates of fungemia and numbers of isolates with reduced azole susceptibility ' (2005 ) 43 J. Clin. Microbiol. : 4434 -4440.

    • Search Google Scholar
  • Messer, S. A., Jones, R. N., Fritsche, T. R.: International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J. Clin. Microbiol. 44, 1782–1787 (2006).

  • Swinne, D., Watelle, M., Suetens, C., Mertens, K., Fonteyne, P.-A., Nolard, N.: A one-year survey of candidaemia in Belgium in 2002. Epidemiol. Infect. 132, 1175–1180 (2004).

    Nolard N. , 'A one-year survey of candidaemia in Belgium in 2002 ' (2004 ) 132 Epidemiol. Infect. : 1175 -1180.

    • Search Google Scholar
  • Tortorano, A. M., Pennan, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., Grillot, R., the ECMM Working Group on Candidaemia: Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study. Eur. J. Clin. Microbiol. Infect. Dis. 23, 317–322 (2004).

    Grillot R. , 'Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study ' (2004 ) 23 Eur. J. Clin. Microbiol. Infect. Dis. : 317 -322.

    • Search Google Scholar
  • Bedini, A., Venturelli, C., Mussini, C., Guaraldi, G., Codeluppi, M., Borghi, V., Rumpianesi, F., Barchiesi, F., Esposito, R.: Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin. Microbiol. Infect. 12, 75–80 (2006).

    Esposito R. , 'Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital ' (2006 ) 12 Clin. Microbiol. Infect. : 75 -80.

    • Search Google Scholar
  • González, G. M., Elizondo, M., Ayala, J.: Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: Results of a 3-year (2004 to 2007) surveillance study. J. Clin. Microbiol. 46, 2902–2905 (2008).

    Ayala J. , 'Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: Results of a 3-year (2004 to 2007) surveillance study ' (2008 ) 46 J. Clin. Microbiol. : 2902 -2905.

    • Search Google Scholar
  • Yapar, N., Uysal, U., Yucesoy, M., Cakir, N., Yuce, A.: Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 49, 134–138 (2006).

    Yuce A. , 'Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital ' (2006 ) 49 Mycoses : 134 -138.

    • Search Google Scholar
  • Pfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C. D. J., Sheehan, D. J., Walsh, T. J.: Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin and micafungin: analysis and proposal for interpretive MIC breakpoints. J. Clin. Microbiol. 46, 2620–2629 (2008).

    Walsh T. J. , 'Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin and micafungin: analysis and proposal for interpretive MIC breakpoints ' (2008 ) 46 J. Clin. Microbiol. : 2620 -2629.

    • Search Google Scholar
  • Sandven, P., Bevanger, L., Digranes, A., Haukland, H. H., Mannsaker, T., Gaustad, P.: Candidaemia in Norway (1991 to 2003): Results from nationwide study. J. Clin. Microbiol. 44, 1977–1981 (2006).

    Gaustad P. , 'Candidaemia in Norway (1991 to 2003): Results from nationwide study ' (2006 ) 44 J. Clin. Microbiol. : 1977 -1981.

    • Search Google Scholar
  • Pfaller, M. A., Diekema, D. J.: Twelve years of fluconazole in clinical practice: Global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin. Microbiol. Infect. 10Suppl. 1, 11–23 (2004).

    Diekema D. J. , 'Twelve years of fluconazole in clinical practice: Global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida ' (2004 ) 10 Clin. Microbiol. Infect. : 11 -23.

    • Search Google Scholar
  • Lee, J. S., Shin, J. H., Lee, K., Kim, M. N., Shin, B. M., Uh, Y., Lee, W. G., Lee, H. S., Chang, C. L., Kim, S. H., Shin, M. G., Suh, S. P., Ryang, D. W.: Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea. Yonsei Med. J. 48, 779–786 (2007).

    Ryang D. W. , 'Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea ' (2007 ) 48 Yonsei Med. J. : 779 -786.

    • Search Google Scholar
  • Tan, T. Y., Tan, A. L., Tee, N. W., Ng, L. S.: A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. Ann. Acad. Med. Singapore 37, 835–840 (2008).

    Ng L. S. , 'A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals ' (2008 ) 37 Ann. Acad. Med. Singapore : 835 -840.

    • Search Google Scholar
  • National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Villanova, PA, NCCLS (1997).

    '', in Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A , (1997 ) -.

  • Odds, F. C., Bernaerts, R.: CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32, 1923–1929 (1994).

    Bernaerts R. , 'CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species ' (1994 ) 32 J. Clin. Microbiol. : 1923 -1929.

    • Search Google Scholar
  • Larone, D. H.: Medically Important Fungi. A guide to identification. 2nd edition. Elsevier Science Publishing Co., Inc. Amsterdam, The Netherlands, 1987, pp. 173–185.

    Larone D. H. , '', in Medically Important Fungi. A guide to identification , (1987 ) -.

  • McGinnis, M. R., Pasarell, L.: Yeast identification using morphology. In: Isenberg, H. D. (ed.): Clinical Microbiology Procedures Handbook. Vol. 1. American Society for Microbiology, Washington, USA, 1992, p. 6.9.

    Pasarell L. , '', in Clinical Microbiology Procedures Handbook. Vol. 1 , (1992 ) -.

  • Etest technical guide No. 4: Antifungal susceptibility testing of yeasts. Solna, Sweden, AB Biodisk (1993).

  • Pfaller, M. A., Diekema, D. J., Rex, J. H., Espinel-Ingroff, A., Johnson, E. M., Andes, D., Chaturvedi, V., Ghannoum, M. A., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Troke, P., Walsch, T. J., Warnock, D. W.: Correlation of MIC with outcome for Candida species tested against voriconazole: Analysis and proposal for interpretive breakpoints. J. Clin. Microbiol. 44, 819–826 (2006).

    Warnock D. W. , 'Correlation of MIC with outcome for Candida species tested against voriconazole: Analysis and proposal for interpretive breakpoints ' (2006 ) 44 J. Clin. Microbiol. : 819 -826.

    • Search Google Scholar
  • Fodor, E., Dósa, E., Nagy, Á., Nagy, E., Ferenczy, L.: Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulse-field gel electrophoresis. Acta Microbiol. Immunol. Hung. 49, 59–68 (2002).

    Ferenczy L. , 'Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulse-field gel electrophoresis ' (2002 ) 49 Acta Microbiol. Immunol. Hung. : 59 -68.

    • Search Google Scholar
  • Lunel, F. V., Koeleman, J. G., Spanjaard, L., Vandenbroucke-Grauls, C., Schultz, C., Verbrugh, H. A., Vos, G., Troelstra, A., Mascini, E., Verweij, P. E., Voss, A.: Trends in fungaemia and antifungal susceptibility in the Netherlands. Neth. J. Medicine 64, 236–242 (2006).

    Voss A. , 'Trends in fungaemia and antifungal susceptibility in the Netherlands ' (2006 ) 64 Neth. J. Medicine : 236 -242.

    • Search Google Scholar
  • Almirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., Saballs, P., Fridkin, S. K., Morgan, J., Rodriguez-Tudela, J. L., Warnock, D. W., Pahissa, A. and the Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 43, 1829–1835 (2005).

    Pahissa A. , 'Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 ' (2005 ) 43 J. Clin. Microbiol. : 1829 -1835.

    • Search Google Scholar
  • Boo, T. W., O’Reilly, B., O’Leary, J., Cryan, B.: Candidaemia in an Irish tertiary referral hospital: Epidemiology and prognostic factors. Mycoses 48, 251–259 (2005).

    Cryan B. , 'Candidaemia in an Irish tertiary referral hospital: Epidemiology and prognostic factors ' (2005 ) 48 Mycoses : 251 -259.

    • Search Google Scholar
  • Dóczi, I., Dósa, E., Hajdú, E., Nagy, E.: Aetilogy and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. J. Med. Microbiol. 51, 677–681 (2002).

    Nagy E. , 'Aetilogy and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000 ' (2002 ) 51 J. Med. Microbiol. : 677 -681.

    • Search Google Scholar
  • Cisterna, R., Ezpeleta, G., Telleria, O., Guinea, J., Regueiro, G., Radríguez, J., Esperalba, J. and the Spanish Candidaemia Surveillance Group: A nationwide sentinel surveillance of bloodstream Candida spp. infection study in 40 tertiary-care hospitals in Spain. J. Clin. Microbiol. 48, 4200–4206 (2010).

    Esperalba J. , 'A nationwide sentinel surveillance of bloodstream Candida spp. infection study in 40 tertiary-care hospitals in Spain ' (2010 ) 48 J. Clin. Microbiol. : 4200 -4206.

    • Search Google Scholar
  • Odds, F. C., Hanson, M. F., Davidson, A. D, Jacobsen, M. D., Wright, P., Whyte, J. A., Gow, N. A., Jones, B. L.: One year prospective survey of Candida bloodstream infections in Scotland. J. Med. Microbiol. 56, 1066–1075 (2007).

    Jones B. L. , 'One year prospective survey of Candida bloodstream infections in Scotland ' (2007 ) 56 J. Med. Microbiol. : 1066 -1075.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
submission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 1 0 0
Jul 2021 5 0 0
Aug 2021 11 0 0
Sep 2021 0 0 0
Oct 2021 6 0 0
Nov 2021 7 0 0
Dec 2021 0 0 0